Biochemist’s research holds promise for novel treatments for cancers and neurological disorders

For UNC Charlotte biochemist Andrew Truman, a quest for new and better treatments for cancers and neurological diseases drives his research into protein folding and the DNA damage response, along with his desire to advance science broadly. To fund his work, he has received three significant National Institutes of Health (NIH) grants expected to total $2 million.

“These are real things that affect real people. They are not theoretical,” Truman said. “Working in our labs, we are curious to understand how cells function. But there are people all over the world affected by these illnesses. We are very privileged to have funding from the NIH to drive this research forward.”

Biochemist’s research holds promise for novel treatments for cancers and neurological disorders